Abstract: The present invention provides a method for analysis and determination of the heavy metal occurrence key mineral phases in industrial solid waste, by performing N concentration gradients dissociation determination of the heavy metal solid waste to be tested under the same dissociation conditions, to give the dissociation degrees of the heavy metal elements to be tested at N different concentration gradients; the dissociated solid residues after dissociation being quantitatively analyzed for the mineral phase, to give the relative content of each mineral phase in the M mineral phases of the heavy metal solid waste to be tested; then calculating to give the occurrence distribution proportion of the heavy metal elements in the mineral phase, which are accumulated from high to low; the occurrence key mineral phase whose cumulative occurrence proportion exceeds the preset cumulative threshold value is determined to be the key mineral phase of the heavy metal elements.

Abstract: A light device comprising a light emitting unit, a voltage control unit, and a current control unit is provided. The light emitting unit is capable of receiving DC power. The voltage control unit has a power input terminal, a power output terminal, and a voltage setting member, with the power input terminal connecting with the light emitting unit, the voltage setting member having a threshold value to control the voltage of the power output terminal in a value equal to or lower than the threshold value. The current control unit has a voltage regulating member and a current adjusting member, with the voltage regulating member connecting with the power output terminal of the voltage control unit and generating a stable DC voltage, and with the current adjusting member connected between the voltage regulating member and a ground point to stabilize a current passing through the current adjusting member.

Abstract: An adjuvant composition comprising noscapine and its derivatives, for use in the treatment of tumors, cancer, as an adjuvant for vaccines.

Abstract: An adjuvant composition comprising noscapine and its derivatives, for use in the treatment of tumors, cancer, as an adjuvant for vaccines.

Abstract: The invention features methods of selecting chemical peaks from two-dimensional magnetic resonance spectra for one-dimensional extraction and quantification methods using these one-dimensional extractions. The methods permit enhanced differentiation of particular peaks in two-dimensional magnetic resonance spectroscopy and allow for quantification of chemical concentrations in test samples, such as human brain tissue, having complex magnetic resonance spectra due to the presence of numerous chemicals. These new techniques can be used to provide information about the concentrations of a variety of chemicals, including metabolites, in both biological and non-biological media.

Abstract: An adjuvant composition comprising noscapine and its derivatives, for use in the treatment of tumors, cancer, as an adjuvant for vaccines.

Abstract: The invention permits measurement of changes in chemical concentrations where the chemicals have the same resonance peak in magnetic resonance spectroscopy. Using this approach, MRS techniques with higher resolution can be used, even though they fail to resolve chemicals of interest into different peaks. The invention can be applied to diagnose diseases, e.g., metabolic disorders, and to measure time-dependent chemical response to sensory or pharmaceutical stimuli.

Abstract: The invention features methods of selecting chemical peaks from two-dimensional magnetic resonance spectra for one-dimensional extraction and quantification methods using these one-dimensional extractions. The methods permit enhanced differentiation of particular peaks in two-dimensional magnetic resonance spectroscopy and allow for quantification of chemical concentrations in test samples, such as human brain tissue, having complex magnetic resonance spectra due to the presence of numerous chemicals. These new techniques can be used to provide information about the concentrations of a variety of chemicals, including metabolites, in both biological and non-biological media.

Abstract: A method for specifically suppressing the capacity of a mammal receiving gene therapy to mount an immune response to a given expressed gene of the deficient gene in question, which response is caused by the administration of "foreign" DNA encoding an antigenic protein or vectors comprising such DNA for expression of the deficient gene in the patient receiving gene therapy.